Lupus Nephritis Archives - Page 11 of 11 - Renal and Urology News

Lupus Nephritis

Shirish Sangle, MD

Rituximab May Not Halt Progression to ESRD

BOSTON—Rituximab is highly effective for treating resistant systemic lupus erythematosus (SLE), but, in certain patients, the medication does not prevent progression to end-stage renal disease (ESRD), British researchers conclude.

lupus nephritis histology

Race, Ethnicity, and SLE Drugs

BOSTON—Among the various racial and ethnic groups in the United States, Hispanics have the worst response to treatment for proliferative nephritis due to systemic lupus erythematosus (SLE), data show.

Traditional Lupus Nephritis Regimen Best

BOSTON—The traditional cyclophosphamide regimen for lupus nephritis recommended by the National Institutes of Health (NIH) is superior to high-dose immunoablative cyclophosphamide, a recent study suggests.

SLE Nephritis is More Common in Males

BOSTON—Kidney involvement stemming from systemic lupus erythematosus (SLE) may be more common in male than female patients, researchers reported at the annual meeting of American College of Rheumatology.

Renal Function at Biopsy Is Key

WASHINGTON, D.C.—The best predictor of outcome in patients with lupus nephritis is kidney function at the time of renal biopsy, supporting the need for early diagnosis and treatment, researchers reported here at the American College of Rheumatology annual meeting.

NO Higher in Proliferative Nephritis

Systemic nitric oxide (NO) levels are elevated in patients with proliferative lupus nephritis, researchers found. The association is independent of renal elimination of nitrate and nitrite (NOx), a measure of NO production.

Next post in News